New York - The newest systemic antibiotics aren't always the best, especially when their overuse creates concerns for drug resistance.
Variable-Sequenced Large-Spot KTP and PDL Demonstrate Comparable Efficacy in Rosacea
The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment
Nivolumab Plus Talazoparib Does Not Induce Responses in Heavily Pretreated Melanoma
ReV Up Your Vitiligo Treatment Strategies
New Dermatology Social Comparison Scale Demonstrates Acceptable Psychometrics for Clinical and Research Applications
Experts Pen 12 Implementable Steps For Addressing Gender Inequity In Academic Dermatology